Seller record · Telehealth service

Nextmeds

By Peptide Alliance, Editorial publisherRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S5, analytical documentation: No certificate of analysis, lot number or testing claim appears on the site. Home, about, contact, terms, privacy and the frequently asked questions carry none. 1 more criterion also fails; see the table below.

At a glance

NextmedsTelehealth service

6/8criteria passed

Price: Semaglutide $79 a month, $49 on a 12-month plan
Sells: compounded semaglutide, compounded tirzepatide
FDA letters: None on file

Visit Nextmeds See all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A telehealth membership selling compounded semaglutide and tirzepatide. It publishes a full plan ladder, and its headline figure is the twelve-month rung rather than the monthly one.

Operating entity Nextmeds, Inc.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Nextmeds' website
S2	Prescription gating	PASS	Nextmeds' website
S3	Pharmacy identification	PASS	Nextmeds' website
S4	Compounding disclosure	PASS	Nextmeds' website
S5	Analytical documentation	FAIL	Nextmeds' website
S6	Business address	FAIL	Nextmeds' privacy page
S7	Price disclosure	PASS	Nextmeds' website
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSMedical services, including clinical evaluation and prescribing, are stated to be provided by OpenLoop Healthcare Partners, PC and its affiliated professional medical practices.Source: Nextmeds' website.

S2PASSAn eligibility intake headed check your eligibility for GLP-1 treatment stops the order, before any product or payment screen.Source: Nextmeds' website.

S3PASSFour pharmacies named with street addresses and telephone numbers: RedRock Pharmacy in St. George, Health Warehouse in Florence, Precision Medicine in Bellmore, and Triad Rx in Daphne.Source: Nextmeds' website.

S4PASSA reader-visible page states the medications are compounded and are not FDA approved or evaluated by the FDA.Source: Nextmeds' website.

S5FAILNo certificate of analysis, lot number or testing claim appears on the site. Home, about, contact, terms, privacy and the frequently asked questions carry none.Source: Nextmeds' website.

S6FAILThe seller prints no street address of its own. Footer, contact, terms and privacy carry one postal address between them, and it belongs to Openloop, Inc. in Alpharetta, Georgia, the clinical platform rather than the seller.Source: Nextmeds' privacy page.

S7PASSA ladder printed on the homepage: compounded semaglutide at 79 dollars monthly, 76 on a 3-month plan, 73 on a 6-month plan and 49 on a 12-month plan; the headline figure is the 12-month rung.Source: Nextmeds' website.

S8PASSNo FDA warning letter names the entity, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide

Visit Nextmeds

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.